within Pharmacolibrary.Drugs.ATC.R;

model R06AA04
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.000225,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0009666666666666667,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R06AA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Clemastine is a first-generation antihistamine (H1 receptor antagonist) used for the relief of allergy symptoms such as hay fever, urticaria, and rhinitis. It is also sometimes used as an adjunct treatment in anaphylactic reactions. Clemastine is generally approved and is available as an over-the-counter medication in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adult individuals after single oral administration; published data on detailed PK modeling (compartmental or non-compartmental) rarely available in the literature.</p><h4>References</h4><ol><li><p>Odell, EP, et al., &amp; Ostrem, BEL (2024). Minimum effective dose of clemastine in a mouse model of preterm white matter injury. <i>Pediatric research</i> 96(4) 933–941. DOI:<a href=&quot;https://doi.org/10.1038/s41390-024-03326-w&quot;>10.1038/s41390-024-03326-w</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38942888/&quot;>https://pubmed.ncbi.nlm.nih.gov/38942888</a></p></li><li><p>Schran, HF, et al., &amp; Gelbert, MB (1996). The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations. <i>Journal of clinical pharmacology</i> 36(10) 911–922. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1996.tb04758.x&quot;>10.1002/j.1552-4604.1996.tb04758.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8930778/&quot;>https://pubmed.ncbi.nlm.nih.gov/8930778</a></p></li><li><p>Törneke, K, et al., &amp; Broström, H (2003). Pharmacokinetics and pharmacodynamics of clemastine in healthy horses. <i>Journal of veterinary pharmacology and therapeutics</i> 26(2) 151–157. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2885.2003.00460.x&quot;>10.1046/j.1365-2885.2003.00460.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12667185/&quot;>https://pubmed.ncbi.nlm.nih.gov/12667185</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R06AA04;
